MabTics Co., Ltd.
PrivateLast Round
Strategic
Jun 1, 2024
Total Funding Raised
$2.57M
Company Overview
MabTics Co., Ltd. is a biotechnology company that develops novel antibody therapeutics based on vessel normalization for treating vascular diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MabTics Co., Ltd. Comparables
Compare MabTics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| INGENIA Therapeutics | 84% | |
| Memento Medicines | 83% | |
| NEORTESBIO Inc. | 83% | |
MabTics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 1, 2024 | ||||
| Strategic | Jul 1, 2023 | ||||
| Seed | Dec 1, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2024
$940K raised with participation from Curacle Co., Ltd.
- Jul 1, 2023
$780K raised from Curacle Co., Ltd.
MabTics Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MabTics Co., Ltd.'s valuation, stock price, and market status.